Dosimetric quantities and cell survival for spatially fractionated radiation therapy

被引:10
|
作者
Ahmed, Mabroor [1 ,2 ,3 ]
Bicher, Sandra [1 ,2 ]
Stewart, Robert D. [4 ]
Bartzsch, Stefan [1 ,2 ]
Schmid, Thomas E. [1 ,2 ]
Combs, Stephanie E. [1 ,2 ]
Meyer, Juergen [4 ]
机构
[1] Tech Univ Munich, Sch Med, Dept Radiat Oncol, Klinikum Rechts Isar, Munich, Germany
[2] Helmholtz Zentrum Munchen GmbH, Inst Radiat Med, German Res Ctr Environm Hlth, Neuherberg, Germany
[3] Tech Univ Munich, Phys Dept, Garching, Germany
[4] Univ Washington, Fred Hutchinson Canc Ctr, Dept Radiat Oncol, Seattle, WA 98195 USA
关键词
microbeam; minibeam; Equivalent Uniform Dose (EUD); biological dose; Relative Effectiveness Factor (REF); Spatially Fractionated Radiation Therapy (SFRT); Microbeam Radiation Therapy (MRT); relative biological effectiveness (RBE); RADIOTHERAPY; TOLERANCE; BOOTSTRAP; BEAMS;
D O I
10.3389/fphy.2022.1064860
中图分类号
O4 [物理学];
学科分类号
0702 ;
摘要
Purpose: Spatially Fractionated Radiation Therapy (SFRT) is characterized by large differences in peak and valley doses. Preclinical and clinical studies suggest that differences in biological mechanisms lead to differential normal tissue and tumor response compared to uniform irradiation. We hypothesize that to evaluate clinical effectiveness and understand fundamental biological mechanisms, radiobiological rather than physical dose quantities should be utilized for comparisons. The aim of this work is to determine whether Equivalent Uniform Dose (EUD) is a superior predictor of cell survival than absorbed dose. Methods: Absorbed dose parameters were compared to the Equivalent Uniform Dose to assess their predictive value for the relative effectiveness of uniform and SFRT with X-rays. A Bayesian bootstrap technique was utilized to model uncertainties in the biological fit parameters for a human fibroblast (MRC5) and two human tumor cell lines (LN18 and A549). Dose uncertainties were evaluated through measurements and error modeling of SFRT profiles. A dimensionless Relative Effectiveness Factor (REF) is proposed to quantify differences between uniform and SFRT irradiation. Results: For all cell lines, cell survival after SFRT matched uniform irradiation within the estimated uncertainties at equal values of the EUD. Average and peak dose showed poor correlation with in vitro cell survival. The proposed REF factor is dose dependent and suggests enhanced cell killing for both tumor cell lines (1.14 +/- .08 for LN18, 1.32 +/- .13 for A549 at 8 Gy EUD) for SFRT. Normal human fibroblasts showed reduced cell killing relative to uniform irradiation (.58 +/- .06 for MRC5). Synthetically generated SFRT dose profiles revealed that EUD uncertainties are dominated by valley dose uncertainties, especially at high doses. Discussion: EUD is more predictive of cell survival than average or valley dose. Valley dose is close to equal to the EUD for values > 10 Gy and has the advantage of being independent of uncertainties in biological parameters. The REF is a novel and useful metric to compare quantitative differences in SFRT and uniform irradiation. Conclusion: EUD is recommended for comparisons of SFRT and uniform irradiation. The results suggest an increase in survival of normal-human fibroblast cells and reduced survival for both tumor cell lines after SFRT relative to uniform irradiation.
引用
收藏
页数:12
相关论文
共 50 条
  • [41] Dosimetric Characterization of 18 MV Beam for a Brass GRID Collimator in Comparison with the 6 MV Beam for Spatially Fractionated Radiation Therapy (SFRT)
    Cui, J.
    Xu, Z.
    Natsuaki, Y.
    Balik, S.
    Woods, K. E.
    Shen, Z. L.
    Ma, L.
    Zhang, H.
    MEDICAL PHYSICS, 2024, 51 (10) : 7957 - 7957
  • [42] Assessment and Development of Plan Quality Metrics for Spatially Fractionated Radiation Therapy
    Kavanaugh, James
    Ginn, John
    Duriseti, Sai
    Mazur, Thomas
    Spraker, Matthew
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2021, 44 (10): : S136 - S137
  • [43] Dosimetric Validation of Spatially Fractionated Radiotherapy Using Gel Dosimetry
    Papanikolaou, P.
    Watts, L.
    Pappas, E.
    Kalaitzakis, G.
    Maris, T.
    Kirby, N.
    Rasmussen, K.
    Gutierrez, A.
    Stathakis, S.
    Pappas, E.
    MEDICAL PHYSICS, 2016, 43 (06) : 3581 - 3581
  • [44] Spatially Fractionated Radiation Therapy (GRID) On Implanted Tumors Using a Small Animal Conformal Radiation Therapy System
    Sharma, S.
    Webber, J.
    Nathan, K.
    Griffin, R.
    Moros, E.
    Corry, P.
    MEDICAL PHYSICS, 2009, 36 (06) : 2514 - +
  • [45] THEORETICAL ISO-SURVIVAL FORMULAE FOR FRACTIONATED RADIATION THERAPY
    COHEN, L
    BRITISH JOURNAL OF RADIOLOGY, 1968, 41 (487): : 522 - &
  • [46] Safety and Efficacy of Spatially Fractionated Radiation Therapy Using Lattice Radiation for Metastatic and/or Bulky Disease
    Li, A.
    Mao, M.
    Xu, B.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : E129 - E129
  • [47] SURVIVAL-CURVE DESCRIPTION FOR FRACTIONATED RADIATION-THERAPY
    KOZUBEK, S
    NEOPLASMA, 1982, 29 (02) : 135 - 148
  • [48] Early clinical results of proton spatially fractionated GRID radiation therapy (SFGRT)
    Mohiuddin, Majid
    Lynch, Connor
    Gao, Mingcheng
    Hartsell, William
    BRITISH JOURNAL OF RADIOLOGY, 2020, 93 (1107):
  • [49] VMAT-Based Spatially Fractionated Radiation Therapy (GRID) for Bulky Tumors
    Zhang, X.
    Morrill, S.
    Yan, Y.
    Langner, U.
    Dyer, M.
    Griffin, R. J.
    Yu, S.
    Penagaricano, J. A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : S238 - S238
  • [50] A Dose Accumulation Assessment of Alignment Errors During Spatially Fractionated Radiation Therapy
    Ginn, John
    Duriseti, Sai
    Mazur, Thomas
    Spraker, Matthew
    Kavanaugh, James
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2021, 44 (10): : S135 - S136